Figure 1.
a) Distribution of DNA length fragments in plasma and serum samples.
b) Differential coverage for next-generation sequencing in tissue and plasma. Sequencing depth was significant higher in plasma to identify low-frequency mutations.
a) Distribution of DNA length fragments in plasma and serum samples.
b) Differential coverage for next-generation sequencing in tissue and plasma. Sequencing depth was significant higher in plasma to identify low-frequency mutations.